Bibliography
- EVANS RW: Coming to terms with reality: why xenotransplantation is a necessity. XeriotranspImitation (2001) 29–51.
- EVANS RW, ORIANS CE, ASCHER NL: The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. Am. Med. Assoc. (1992) 267:239–246.
- CASCALHO M, PLATT JL: Xenotransplantation and other means of organ replacement. Nat. Rev. Immuriol (2001) 1:154–160.
- •This paper explores how xenotransplantation, organogenesis and artificial organs might be used in future efforts to replace or supplement human organ function.
- PRINCETEAU M: Greffe renale. j Med. Bordeaux (1905) 36:549–555.
- CASCALHO M, PLATT JL: The immunological barrier to xenotransplantation. Immunity (2001) 14:437–446.
- DORLING A, LOMBARDI G, BINNS R et al.: Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur. Immuriol (1996) 26:1378–1387.
- HAMMER C: Physiological obstacles after xenotransplantation. Ann. NY Acad. Li. (1998) 862:19–27.
- LAWSON JH, PLATT JL: Molecular barriers to xenotransplantation. Transplantation (1996) 62:303–310.
- PATIENCE C, TAKEUCHI Y, WEISS RA: Zoonosis in xenotransplantation. Curr. Opiri. Immuriol (1998) 10:539–542.
- MARTIN U, KIESSIG V, BLUSCH JH et al.: Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 352:692–694.
- BLAU HM, SPRINGER ML: Muscle-mediated gene therapy. N Engl. j Med. (1995) 333:1554–1556.
- TANNER FC, CARR DP, NABEL GJ et al: Transfection of human endothelial cells. Cardiovascular Res. (1997) 35:522–528.
- FERRY N, HEARD JM: Liver-directed gene transfer vectors. Hum. Gene Ther. (1998) 9:1975–1981.
- SCHIEDNER G, MORRAL N, PARKS RJ: Genomic DNA transfer with a high capacity adenovirus results in improved gene expression and decreased toxicity. Nat. Genet. (1998) 18:180–183.
- WILMUT I, SCHNIEKE AE, MCWHIR J et al.: Viable offspring derived from fetal and adult mammalian cells. Nature (1997) 385:810–813.
- KATO Y, TANI T, SOTOMARU Y et al: Eight calves cloned from somatic cells of a single adult. Science (1998) 282:2095–2098.
- WAKAYAMA T, PERRY AC, ZUCCOTTI M etal.: Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature (1998) 394:315–316.
- ••References [16-18] represent early efforts toclone pigs, calves and mice, respectively, using nuclear transfer.
- PLATT JL: Hyperacute xenograft rejection. In: Medical Intelligence Unit (1995) RG Landes, Austin, USA.
- GALILI U: Interaction of the natural anti-Gal antibody with ot-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immuriol Today(1993) 14:480–482.
- GOOD AH, COOPER DKC, MALCOLM AJ et al.: Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. (1992) 24:559–562.
- SANDRIN MS, VAUGHAN HA, DABKOWSKI PL et al.: Anti-pig IgM antibodies in human serum react predominantly with Gala(1,3)Gal epitopes. Proc. Natl. Acad. Li. USA (1993) 90:11391–11395.
- PLATT JL, VERCELLOTTI GM, DALMASSO AP et al.: Transplantation of discordant xenografts: a review of progress. Immuriol Today (1990) 11:450–456.
- ••This paper was the first to propose geneticengineering as an approach to further xenotransplantation and the first to formally describe accommodation.
- DALMASSO AP, VERCELLOTTI GM, PLATT JL et al.: Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplant. (1991) 52:530–533.
- COOPER DKC, HUMAN PA, LEXER Get al.: Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. j Heart Transplant. (1988) 7:238–246.
- LIN SS, WEIDNER BC, BYRNE GW et al:The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. j Chi]. Invest. (1998) 101:1745–1756.
- LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al.: Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 55:857–866.
- PRUITT SK, KIRK AD, BOLLINGER RR et al.: The effect of soluble complement receptor Type 1 on hyperacute rejection of porcine xenografts. Transplantation (1994) 57:363–370.
- CANDINAS D, LESNIKOSKI BA, ROBSON SC et al: Effects of repetitive high-dose treatment with soluble complement receptor Type 1 and cobra venom factor on discordant xenograft survival. Transplantation (1996) 62:336–342.
- KROSHUS TJ, ROLLINS SA, DALMASSO AP etal.: Complement inhibition with an anti-05 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplantation (1995) 60:1194–1202.
- COTTERELL AH, COLLINS BH, PARKER W et al.: The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation (1995) 60:861–868.
- WANG H, ROLLINS SA, GAO Z etal.: Complement inhibition with an anti-05 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation (1999) 70:697–698.
- FODOR WL, WILLIAMS BL, MATIS LA et al.: Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Li. USA (1994) 91:11153–11157.
- LANGFORD GA, YANNOUTSOS N, COZZI E et al.: Production of pigs transgenic for human decay accelerating factor. Transplant Proc. (1994) 26:1400–1401.
- MC CURRY KR, KOOYMAN DL, ALVARADO CG et al.: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. (1995) 1:423–427.
- ••This paper reports the first use of geneticengineering of pigs in xenotransplantation.
- SCHMOECKEL M, BHATTI FNK, ZAIDI A etal.: Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation (1998) 65:1570–1577.
- ZAIDI A, BHATTI F, SCHMOECKEL M et al.: Kidneys from HDAF transgenic pigs are physiologically compatible with primates. Transplant. Proc. (1998) 30:2465–2466.
- SCHMOECKEL M, NOLLERT G, SHAHMOHAMMADI M et al.: Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation (1996) 62:729–734.
- BYRNE GW, MCCURRY KR, MARTIN MJ etal.: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation (1997) 63:149–155.
- ONISHI A, IWAMOTO M, AKITA T et al.:Pig cloning by microinjection of fetal fibroblast nuclei. Science (2000) 289:1188–1190.
- POLEJAEVA IA, CHEN S, VAUGHT TD et al.: Cloned piglets produced by nuclear transfer from adult somatic cells. Nature (2000) 407:86–90.
- •References [36,37] report cloning of pigs via nuclear transfer and suggest the possibility of using cloning to knock out galactosyltransferase.
- BETTHAUSER J, FORSBERG E, AUGENSTEIN M et al.: Production of cloned pigs from in vitro systems. Nat. Biotechnol. (2000) 18:1055–1059.
- SANDRIN MS, FODOR WL, MOUHTOURIS E et al.: Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat. Med. (1995) 1:1261–1267.
- •This paper reports the first attempt to genetically modify expression of antigen of import in the development of vascular disease in xenotransplantation.
- SHARMA A, OKABE JF, BIRCH P et al.: Reduction in the level of Gal (al, 3) Gal in transgenic mice and pigs by the expression of an a(1,2) fucosyltransferase. Proc. Nati Acad. Sci. USA (1996) 93:7190–7195.
- LEVENTHAL JR, MATAS AJ, SUN LH et al.: The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation (1993) 56:1–8.
- LIN SS, PLATT JL: Immunologic barriers to xenotransplantation. I Heart Lung Transplant. (1996) 15:547–555.
- PORTER KA: Renal transplantation. In: Pathology of the Kidney.. Heptinstall RH (Ed.), Little Brown and Company, Boston, USA (1992):1799–1933.
- GACA JG, LEE W, AKSOY O et al.: Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation. Trawl. Immunol. (2001) 9:19–27.
- •This paper provides evidence that human serum contains polyreactive antibodies specific for epitopes other than Galoc1-3Gal and that these antibodies are more xenoreactive than autoreactive.
- LIN SS, HANAWAY MJ, GONZALEZ-STAWINSKI GV et al.: The role of anti-Gala1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (2000) 70:1667-1674. Personal communication.
- BLAKELY ML, VAN DER WERF WJ, BERNDT MC et al.: Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation (1994) 58:1059–1066.
- MALYGUINE AM, SAADI S, HOLZKNECHT RA et al.: Induction of procoagulant function in porcine endothelial cells by human NK cells. I konurrol. (1997) 159:4659–4664.
- PLATT JL, LIN SS, MCGREGOR CGA: Acute vascular rejection. Xerrotransplantation (1998) 5:169–175.
- ••This paper suggests one approach toachieving tolerance - expression of donor antigen on recipient bone marrow cells.
- BRACY JL, SACHS DH, IACOMINI J: Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science (1998) 281:1845–1847.
- CHOPEK MW, SIMMONS RL, PLATT JL: ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc. (1987) 19:4553–4557.
- ••This paper reports the expression ofprotective genes, which may be involved in, or are essential for, accommodation.
- BACH FH, FERRAN C, HECHENLEITNER P et al.: Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. (1997) 3:196–204.
- BACH FH, FERRAN C, SOARES M etal.: Modification of vascular responses in xenotransplantation: Inflammation and apoptosis. Nat. Med. (1997) 3:944–948.
- FERRAN C, BADRICHANI AZ, COOPER JT et al.: Xenotransplantation: progress toward clinical development. Adv. Nephrol. Necker Hosp. (1997) 27:391–420.
- FERRAN C, STROKA DM, BADRICHANI AZ etal.: Adenovirus-mediated gene transfer of A20 renders endothelial cells resistane to activation: a means of evaluating the role of endothelial cell activation in xenograft rejection. Transplant Proc. (1997) 29:879–880.
- VON ALBERTINI M, FERRAN C, BROSTJAN C et al.: Membrane-associated lymphotoxin on natural killer cells activates endothelial cells via an NF-kappaB-dependent pathway. Transplantation (1998) 66:1211–1219.
- KIRK AD, LI RA, KINCH MS etal.: Thehuman antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation (1993) 55:924–931.
- ELSEN M, SOARES M, LATINNE D et al.:Role of associated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft. Transplant. Proc. (1993) 25:447–449.
- MURRAY AG, KHODADOUST MM, POBER JS et al.: Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. harmunity (1994) 1:57–63.
- DORLING A, STOCKER C, TSAO T et al.: In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation (1996) 62:1127–1136.
- WALDMANN H: Therapeutic approaches for transplantation. Curl: Opin. ImmurroL (2001) 13:606–610.
- ZAIDI A, SCHMOECKEL M, BHATTI F et al.: Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation (1998) 65:1584–1590.
- GROTH CG: Xenotransplantation. The viral issue. Lancet (1998) 352:5IV26.
- RESTIFO AC, IVIS-WOODWARD MA, TRAN et al.: The potential role for xenogeneic antigen presenting cells in T cell co-stimulation. Xerrotransplantation (1996) 3:141–181.
- AKHTER SA, SKAER CA, KYPSON AP et al.: Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Natl. Acad. Li. USA (1997) 94:12100–12105.
- KYPSON AP, PEPPEL K, AKHTER SA et al.: Ex vivo adenoviral-mediated gene transfer to the adult rat heart. j Thorac. Cardiovasc. Surg. (1998) 115:623–630.
- SHAPIRO AM, LAKEY JR, RYAN EA etal.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl. j Med. (2000) 343:230–238.
- FOX IJ, CHOWDHURY JR, KAUFMAN SS etal.: Treatment of the Crigler-Najjar syndrome Type I with hepatocyte transplantation. N Engl. j Med. (1998) 338:1422–1426.
- MENASCHE E HAGEGE AA, SCORSIN M et al.: Myoblast transplantation for heart failure. Lancet (2001) 357:279–280.
- DEACON T, SCHUMACHER J, DINSMORE J et al.: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. (1997) 3:350–353.
- GRITSCH HA, GLASER RM, EMERY DW et al.: The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation (1994) 57:906–917.
- JAEGER C, WOHRLE M, FEDERLIN K et al.: Pancreatic islet xenografts at two different transplantation sites (renal subcapsular versus intraportal): comparison of graft survival and morphology. Exp. Chi]. EndocrirroL Diabetes (1995) 103:123–128.
- KAUFMAN DB, PLATT JL, RABE FL etal.: The immunological basis of islet allograft primary non-function. j Exp. Med. (1990) 172:291–302.
- GIANNOUKAKIS N, RUDERT WA, GHIVIZZANI S etal.: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents I1-1-beta-induced dysfunction and apoptosis activation in vitro. Diabetes (1999) 48:1730–1736.
- MAKAROV SS, JOHNSTON WN, OLSEN JC etal.: NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Ther. (1997) 4:846–852.
- BONDESON J, BROWNE KA, BRENNAN FM etal.: Selective regulation of cytokine induction by adenoviral gene transfer of I kappa B alpha into human macrophages: lipopolysaccharide-induced, but not zymosan - induced proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappa B independent. j ImmurroL (1999) 162:2939–2945.
- BENHAMOU PY, MULLEN Y, SHAKED A etal.: Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation (1996) 62:1306–1312.
- OKADA Y, SAITO S, FUJISAWA K et al.:Adenovirus-mediated viral IL-10 gene transfer prolongs survival of xenogeneic spheroidal aggregate-cultured hepatocytes. Transplant. Int. (2000) 13:S485–S493.
- PATIENCE C, TAKEUCHI Y, WEISS RA: Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. (1997) 3:282–286.
- HENEINE W, TIBELL A, SWITZER WM et al.: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 352:695–699.
- PATIENCE C, PATTON GS, TAKEUCHI Y et al.: No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet (1998) 352:699–701.
- ••This paper reports that PERV infection doesnot occur in human patients exposed to porcine cells.
- PARADIS K, LANGFORD G, LONG Z et al.: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science (1999) 285:1236–1241.
- OGLE BM, PLATT JL: Approaches to thereplacement of the function of failing organs. Curr. Opin. Organ Transplarm In Press.
- DEKKERS RJ, FITZGERALD DJ, COUPER GS: Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion (2001) 16:13–28.
- TAYLOR DA, ATKINS BZ, HUNGSPREUGS P etal.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. (1998) 4:929–933.
- DAGGETT CW, YEATMAN M, LODGE AJ et al.: Total respiratory support from swine lungs in primate recipients. j Thome. Cardiovasc. Surg. (1998) 115:19–27.
- HOLZKNECHT ZE, COOMBES S, BLOCHER BA etal.: Immune complex formation after xenotransplantation: evidence of Type III as well as Type II immune reactions provide clues to pathophysiology. Am. j PathoL (2001) 158:627–637.
- LAU CL, DAGGETT WC, YEATMAN MF et al.: The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. Thome. Cardiovasc. Surg. (2000) 120:29–38.
- CZERNIAK BJ, SARNIA V, PIERSON CL et al.: Protective effects of C5a blockade in sepsis. Nat. Med. (1999) 5:788–792.
- GROBSTEIN C: Inductive epithelio-mesenchymal interaction in cultured organ rudiments of the mouse. Science (1953) 118:52–55.
- ROGERS SA, LOWELL JA, HAMMERMAN NA etal.: Transplantation of developing metanephroi into adult rats. Kidney Int. (1998) 54:27–37.
- KOBAYASHI N, FUJIWARA T, WESTERMAN KA et al.: Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 287:1258–1262.
- ITO M, NAGATA H, CAI J et al: Treatment of cirrhosis and liver failure by hepatocyte xenotransplantation. Submitted.
- GUNSALUS JR, BRADY DA, COULTER SM et al.: Reduction of serum cholesterol in watanabe rabbits by xenogeneic hepatocellular transplantation. Nat. Med. (1997) 3:48–53.
Website
- www.unos.org/Data/anrpt_main.htm Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989–1998. (February 21 2000). Rockville, MD and Richmond, VA, USA: HHS/HRSA/OSP/DOT and UNOS. (1999).
- •The UNOS website offers up-to-date information on the supply and demand of organs for transplant.